Cohen Klingenstein’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Hold |
47,559
| – | – | 0.07% | 113 |
|
|
2025
Q1 | $2.9M | Hold |
47,559
| – | – | 0.11% | 91 |
|
|
2024
Q4 | $2.69M | Sell |
47,559
-21,000
| -31% | -$1.19M | 0.09% | 96 |
|
|
2024
Q3 | $3.55M | Sell |
68,559
-841
| -1% | -$43.5K | 0.12% | 96 |
|
|
2024
Q2 | $2.88M | Hold |
69,400
| – | – | 0.1% | 101 |
|
|
2024
Q1 | $3.76M | Hold |
69,400
| – | – | 0.14% | 93 |
|
|
2023
Q4 | $3.56M | Hold |
69,400
| – | – | 0.15% | 92 |
|
|
2023
Q3 | $4.03M | Hold |
69,400
| – | – | 0.18% | 82 |
|
|
2023
Q2 | $4.44M | Hold |
69,400
| – | – | 0.19% | 79 |
|
|
2023
Q1 | $4.81M | Hold |
69,400
| – | – | 0.23% | 74 |
|
|
2022
Q4 | $4.99M | Hold |
69,400
| – | – | 0.25% | 71 |
|
|
2022
Q3 | $4.93M | Hold |
69,400
| – | – | 0.26% | 68 |
|
|
2022
Q2 | $5.34M | Hold |
69,400
| – | – | 0.27% | 66 |
|
|
2022
Q1 | $5.07M | Hold |
69,400
| – | – | 0.21% | 77 |
|
|
2021
Q4 | $4.33M | Sell |
69,400
-13,654
| -16% | -$851K | 0.17% | 90 |
|
|
2021
Q3 | $4.91M | Sell |
83,054
-12,062
| -13% | -$714K | 0.21% | 79 |
|
|
2021
Q2 | $6.36M | Hold |
95,116
| – | – | 0.27% | 66 |
|
|
2021
Q1 | $6.01M | Hold |
95,116
| – | – | 0.28% | 68 |
|
|
2020
Q4 | $5.9M | Hold |
95,116
| – | – | 0.29% | 66 |
|
|
2020
Q3 | $5.74M | Hold |
95,116
| – | – | 0.32% | 66 |
|
|
2020
Q2 | $5.59M | Hold |
95,116
| – | – | 0.34% | 65 |
|
|
2020
Q1 | $5.3M | Hold |
95,116
| – | – | 0.39% | 59 |
|
|
2019
Q4 | $6.11M | Buy |
95,116
+50,116
| +111% | +$3.22M | 0.35% | 66 |
|
|
2019
Q3 | $2.28M | Buy |
45,000
+21,000
| +88% | +$1.06M | 0.14% | 116 |
|
|
2019
Q2 | $1.09M | Buy |
+24,000
| New | +$1.09M | 0.08% | 145 |
|